Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Mir

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 9, 2017
Targeting angiogenesis in advanced soft tissue sarcoma: tivozanib-hype or me-too?O Mir, N Penel
American Journal of Obstetrics and Gynecology|April 9, 2008
Feasibility of platinum-based chemotherapy during pregnancyP Berveiller, J Adam, O Mir
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 16, 2014
Drug selection and dosing in pregnant cancer patients: insights from clinical pharmacokineticsP Berveiller, L Selleret, O Mir
Bulletin Du Cancer|June 11, 2010
[Chemotherapy in unfit bladder cancer patients]F Goldwasser, O Mir, S Ropert
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 2015
Pharmacokinetic and pharmacodynamic end points with anti-VEGFR: the more it hurts, the more it works?O Mir, S Dumont, J-P Armand
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2006
Oxaliplatin in inoperable or metastatic bladder cancerO Mir, J Alexandre, S Ropert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 2009
Hypertension as a surrogate marker for the activity of anti-VEGF agentsO Mir, S Ropert, J Alexandre, et al.
Journal of Gynecology Obstetrics and Human Reproduction|September 4, 2017
Is anagrelide safe during pregnancy?N Cornet, F Vialard, O Mir, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 26, 2021
Essential digital healthF Scotte, O Mir, M Di Palma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2017
Curcumin dietary supplements and everolimus-based cancer treatmentO Mir, S Ropert, A N Chamseddine, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 9, 2017
Targeting angiogenesis in advanced soft tissue sarcoma: tivozanib-hype or me-too?O Mir, N Penel
American Journal of Obstetrics and Gynecology|April 9, 2008
Feasibility of platinum-based chemotherapy during pregnancyP Berveiller, J Adam, O Mir
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 16, 2014
Drug selection and dosing in pregnant cancer patients: insights from clinical pharmacokineticsP Berveiller, L Selleret, O Mir
Bulletin Du Cancer|June 11, 2010
[Chemotherapy in unfit bladder cancer patients]F Goldwasser, O Mir, S Ropert
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 2015
Pharmacokinetic and pharmacodynamic end points with anti-VEGFR: the more it hurts, the more it works?O Mir, S Dumont, J-P Armand
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2006
Oxaliplatin in inoperable or metastatic bladder cancerO Mir, J Alexandre, S Ropert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 2009
Hypertension as a surrogate marker for the activity of anti-VEGF agentsO Mir, S Ropert, J Alexandre, et al.
Journal of Gynecology Obstetrics and Human Reproduction|September 4, 2017
Is anagrelide safe during pregnancy?N Cornet, F Vialard, O Mir, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 26, 2021
Essential digital healthF Scotte, O Mir, M Di Palma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2017
Curcumin dietary supplements and everolimus-based cancer treatmentO Mir, S Ropert, A N Chamseddine, et al.
Pageof 8